Trey C. Mullikin
Papers
1
Total Citations
26
H-Index
1
About
Dr. Trey C. Mullikin is a leading radiation oncologist whose research focuses on advancing proton therapy for gastrointestinal and liver malignancies, particularly hepatocellular carcinoma (HCC). His most cited work, "Intensity Modulated Proton Therapy for Hepatocellular Carcinoma: Initial Clinical Experience" (2021, 26 citations), established the safety and efficacy of IMPT for HCC, demonstrating how this precise modality can deliver curative doses while sparing critical liver tissue. This foundational study has shaped clinical protocols for treating liver tumors with proton beam therapy. Dr. Mullikin's broader contributions include optimizing radiation techniques to minimize toxicity and improve outcomes for patients with complex abdominal cancers. His research bridges the gap between advanced physics and patient-centered care, earning him recognition as an emerging authority in proton therapy. Through his work, Dr. Mullikin continues to refine treatment paradigms, offering new hope for patients with historically challenging diagnoses.
Research Focus
Key Achievements
Top Papers
- 1